178 related articles for article (PubMed ID: 37582888)
1. [Diagnostics and management of patients with inherited retinal diseases in Germany : Results of a nationwide survey of university and non-university eye departments and specialized practices].
Künzel SH; Mahren E; Morr M; Holz FG; Lorenz B;
Ophthalmologie; 2023 Nov; 120(11):1127-1137. PubMed ID: 37582888
[TBL] [Abstract][Full Text] [Related]
2. Current Management of Patients with RPE65 Mutation Associated Inherited Retinal Degenerations in Europe: Results of a 2-Year Follow-Up Multinational Survey.
Lorenz B; Tavares J; van den Born LI; Marques JP; Pilotto E; Stingl K; Charbel Issa P; Leroux D; Dollfus H; Scholl HPN
Ophthalmic Res; 2023; 66(1):727-748. PubMed ID: 36878196
[TBL] [Abstract][Full Text] [Related]
3. Current Management of Patients with RPE65 Mutation-Associated Inherited Retinal Degenerations in Europe: Results of a Multinational Survey by the European Vision Institute Clinical Research Network.
Lorenz B; Tavares J; van den Born LI; Marques JP; Scholl HPN;
Ophthalmic Res; 2021; 64(5):740-753. PubMed ID: 33684911
[TBL] [Abstract][Full Text] [Related]
4. RPE65-associated inherited retinal diseases: consensus recommendations for eligibility to gene therapy.
Sodi A; Banfi S; Testa F; Della Corte M; Passerini I; Pelo E; Rossi S; Simonelli F;
Orphanet J Rare Dis; 2021 Jun; 16(1):257. PubMed ID: 34088339
[TBL] [Abstract][Full Text] [Related]
5. Voretigene Neparvovec: A Review in RPE65 Mutation-Associated Inherited Retinal Dystrophy.
Kang C; Scott LJ
Mol Diagn Ther; 2020 Aug; 24(4):487-495. PubMed ID: 32535767
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of Mutations in the 65-kDa Retinal Pigment Epithelium (RPE65) Gene-Mediated Inherited Retinal Dystrophies: A Systematic Literature Review.
Sallum JMF; Kaur VP; Shaikh J; Banhazi J; Spera C; Aouadj C; Viriato D; Fischer MD
Adv Ther; 2022 Mar; 39(3):1179-1198. PubMed ID: 35098484
[TBL] [Abstract][Full Text] [Related]
7. Perspectives of people with inherited retinal diseases on ocular gene therapy in Australia: protocol for a national survey.
Mack HG; Chen FK; Grigg J; Jamieson R; De Roach J; O'Hare F; Britten-Jones AC; McGuinness M; Tindill N; Ayton L;
BMJ Open; 2021 Jun; 11(6):e048361. PubMed ID: 34158306
[TBL] [Abstract][Full Text] [Related]
8. [Inherited retinal dystrophy: first results of RPE65 gene replacement therapy in Russia].
Kadyshev VV; Zolnikova IV; Khalanskaya OV; Stepanova AA; Kutsev SI
Vestn Oftalmol; 2022; 138(4):48-57. PubMed ID: 36004591
[TBL] [Abstract][Full Text] [Related]
9. Voretigene neparvovec-rzyl for treatment of
Ciulla TA; Hussain RM; Berrocal AM; Nagiel A
Expert Opin Biol Ther; 2020 Jun; 20(6):565-578. PubMed ID: 32149547
[No Abstract] [Full Text] [Related]
10. [Inherited retinal diseases in Germany-Challenges in health care supply structure and diagnostics].
Bolz HJ; Kochs CL; Holz FG; Bucher F; Herrmann P
Ophthalmologie; 2023 Dec; 120(12):1251-1257. PubMed ID: 37606831
[TBL] [Abstract][Full Text] [Related]
11. Inherited Retinal Diseases Due to
Aoun M; Passerini I; Chiurazzi P; Karali M; De Rienzo I; Sartor G; Murro V; Filimonova N; Seri M; Banfi S
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281261
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of voretigene neparvovec in the treatment of patients with inherited retinal disease with RPE65 mutation in Switzerland.
Bhadhuri A; Dröschel D; Guldimann M; Jetschgo C; Banhazi J; Schwenkglenks M; Sutherland CS
BMC Health Serv Res; 2022 Jun; 22(1):837. PubMed ID: 35765055
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy for inherited retinal diseases: progress and possibilities.
Hu ML; Edwards TL; O'Hare F; Hickey DG; Wang JH; Liu Z; Ayton LN
Clin Exp Optom; 2021 May; 104(4):444-454. PubMed ID: 33689657
[TBL] [Abstract][Full Text] [Related]
14. Cost Effectiveness of Voretigene Neparvovec for RPE65-Mediated Inherited Retinal Degeneration in Germany.
Uhrmann MF; Lorenz B; Gissel C
Transl Vis Sci Technol; 2020 Aug; 9(9):17. PubMed ID: 32879773
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of Voretigene Neparvovec-rzyl vs Standard Care for RPE65-Mediated Inherited Retinal Disease.
Johnson S; Buessing M; O'Connell T; Pitluck S; Ciulla TA
JAMA Ophthalmol; 2019 Oct; 137(10):1115-1123. PubMed ID: 31318398
[TBL] [Abstract][Full Text] [Related]
16. An Economic Evaluation of Voretigene Neparvovec for the Treatment of Biallelic RPE65-Mediated Inherited Retinal Dystrophies in the UK.
Viriato D; Bennett N; Sidhu R; Hancock E; Lomax H; Trueman D; MacLaren RE
Adv Ther; 2020 Mar; 37(3):1233-1247. PubMed ID: 32034665
[TBL] [Abstract][Full Text] [Related]
17. Current Management of Inherited Retinal Degeneration Patients in Europe: Results of a 2-Year Follow-Up Multinational Survey by the European Vision Institute Clinical Research Network - EVICR.net.
Lorenz B; Tavares J; van den Born LI; Marques JP; Pilotto E; Stingl K; Charbel Issa P; Leroux D; Dollfus H; Scholl HPN; ;
Ophthalmic Res; 2023; 66(1):550-568. PubMed ID: 36592621
[TBL] [Abstract][Full Text] [Related]
18. Gene Therapy in Hereditary Retinal Dystrophies: The Usefulness of Diagnostic Tools in Candidate Patient Selections.
Malvasi M; Casillo L; Avogaro F; Abbouda A; Vingolo EM
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762059
[TBL] [Abstract][Full Text] [Related]
19. Can artificial intelligence accelerate the diagnosis of inherited retinal diseases? Protocol for a data-only retrospective cohort study (Eye2Gene).
Nguyen Q; Woof W; Kabiri N; Sen S; Daich Varela M; Cabral De Guimaraes TA; Shah M; Sumodhee D; Moghul I; Al-Khuzaei S; Liu Y; Hollyhead C; Tailor B; Lobo L; Veal C; Archer S; Furman J; Arno G; Gomes M; Fujinami K; Madhusudhan S; Mahroo OA; Webster AR; Balaskas K; Downes SM; Michaelides M; Pontikos N;
BMJ Open; 2023 Mar; 13(3):e071043. PubMed ID: 36940949
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
